A Novel Validated UHPLC Method for the Estimation of Rosuvastatin and Its Complete Impurity Profile in Tablet Formulations
Molecules · 03.01.2023 · 28 (1) · 431
DOI: 10.3390/molecules28010431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 03.01.2023. Verfasst von Francesca Romana Mammone und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for the Control and Evaluation of Medicines, Chemical Medicines Unit, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Rosuvastatin Calcium. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A key step in the development of medicinal products is the research and validation of selective and sensitive analytical methods for the control of impurities from synthesis and degradation. As most impurities are similar in structure to the drug substance, the achievement of chemo-selective conditions is usually challenging. Herein, a direct and highly selective ultra-high-performance liquid chromatographic method for determining the assay and related substances content in medicinal products containing rosuvastatin calcium salt (RSV) is presented. RSV is used to treat high cholesterol levels and prevent heart attacks and strokes. The most engaging feature of this method was the baseline separation of all organic related substances listed in the European Pharmacopoeia (EP) monograph for the RSV tablets, achieved for the first time in less than 15 min using the Acquity BEH C18 (100 mm × 2.1 mm, 1.7 μm) column under reversed-phase isocratic conditions. The mobile phase adopted for the chemo-selective analysis does not contain buffers but instead contains trifluoroacetic as an acid additive. The chromatographic method was validated according to the guidelines of the International Conference on Harmonization (ICH) and proved to be linear, precise and accurate for determining the content of RSV and related chiral substances in tablet formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for the Control and Evaluation of Medicines, Chemical Medicines Unit, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
ORCID-Profile: Giuseppe La Regina, Romano Silvestri, Roberto Cirilli
Zitieren
APA
Mammone, F. R., Zanitti, L., Puxeddu, M., La Regina, G., Silvestri, R., Borioni, A., & Cirilli, R. (2023). A Novel Validated UHPLC Method for the Estimation of Rosuvastatin and Its Complete Impurity Profile in Tablet Formulations. Molecules, 28(1), 431. https://doi.org/10.3390/molecules28010431
Vancouver
Mammone FR, Zanitti L, Puxeddu M, La Regina G, Silvestri R, Borioni A, et al. A Novel Validated UHPLC Method for the Estimation of Rosuvastatin and Its Complete Impurity Profile in Tablet Formulations. Molecules. 2023;28(1):431. doi:10.3390/molecules28010431
BibTeX
@article{Mammone2023,
author = {Mammone, Francesca Romana and Zanitti, Leo and Puxeddu, Michela and La Regina, Giuseppe and Silvestri, Romano and Borioni, Anna and Cirilli, Roberto},
title = {A Novel Validated UHPLC Method for the Estimation of Rosuvastatin and Its Complete Impurity Profile in Tablet Formulations},
journal = {Molecules},
year = {2023},
volume = {28},
number = {1},
pages = {431},
doi = {10.3390/molecules28010431}
}
EUVIMED